Mizuho Securities USA’s Celgene Corp CELG Stock Holding History

Mizuho Securities USA’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-131,000	Closed	-$15.2M	–	287
2016 Q4	$15.2M	Buy	131,000 +57,300	+78%	+$6.38M	0.63%	16
2016 Q3	$7.7M	Buy	73,700 +63,700	+637%	+$6.89M	0.64%	23
2016 Q2	$986K	Buy	+10,000	New	+$1.03M	0.16%	85
2015 Q3	–	Sell	-26,456	Closed	-$3.06M	–	225
2015 Q2	$3.06M	Buy	26,456 +3,438	+15%	+$393K	0.37%	28
2015 Q1	$2.65M	Sell	23,018 -34,437	-60%	-$4.12M	0.34%	59
2014 Q4	$6.43M	Buy	57,455 +43,532	+313%	+$4.59M	0.63%	38
2014 Q3	$1.32M	Buy	+13,923	New	+$1.26M	0.15%	56
2014 Q1	–	Sell	-99,482	Closed	-$8.4M	–	144
2013 Q4	$8.4M	Buy	99,482 +28,536	+40%	+$2.26M	0.69%	36
2013 Q3	$5.46M	Sell	70,946 -13,492	-16%	-$946K	0.35%	41
2013 Q2	$4.94M	Buy	+84,438	New	+$5.08M	0.24%	47

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mizuho Securities USA's CELG Position: Q1 2017 in Review

Mizuho Securities USA sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 131,000 shares — an estimated $15.2M sold.

Mizuho Securities USA first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $15.2M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Mizuho Securities USA reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Mizuho Securities USA sold 131,000 Celgene Corp shares in Q1 2017, an estimated $15.2M.
Mizuho Securities USA first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
Mizuho Securities USA's Celgene Corp position peaked at $15.2M in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Mizuho Securities USA's 13F filing for Q1 2017, filed 5 May 2017.